Huaren Pharmaceutical Co.,Ltd.’s Net Profit Rose 4.8% in First Three Quarters of 2022

Huaren Pharmaceutical Co.,Ltd. (华仁药业股份有限公司) (300110.SZ) reported a net profit of 126.3 million yuan in the first three quarters of 2022, up 4.8% year-on-year.

Meanwhile, the company posted 1.1 billion yuan in revenue, down 2.5% year-on-year.

At the end of the reporting period, it had 5.1 billion yuan in total assets and 2.6 billion yuan in total liabilities, with a liability-to-asset ratio of 50.2%.